title: Timunox increases resistance to the challenge with a low number of cells from Yoshida ascites tumor.
authors.affiliation: Istituto Policattedra di Patologia Generale, Università di Messina, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Licastro
authors.forename: C
authors.initials: C
authors.lastname: Bottari
authors.forename: A
authors.initials: A
authors.lastname: Cavallaro
authors.forename: T
authors.initials: T
authors.lastname: Ainis
authors.forename: V
authors.initials: V
authors.lastname: Fimiani
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D045744:Cell Line, Tumor; D004195:Disease Models, Animal; D051381:Rats; D017207:Rats, Sprague-Dawley; D012517:Sarcoma, Yoshida / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D016305:Thymopentin / Q000627:therapeutic use*
chemical_list: D000276:Adjuvants, Immunologic; D016305:Thymopentin